Co-Diagnostics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $11.9M | $2.9M | $14.9M | $23.0M | $88.6M | $43.0M | $893.1K | $950.2K |
| Accounts Receivable | $190.4K | $132.6K | $303.9K | $3.5M | $20.8M | $12.1M | $131.4K | $13.4K |
| Inventory | $992.4K | $1.1M | $1.7M | $5.3M | $2.0M | $8.0M | $197.2K | $18.2K |
| Total Current Assets | $13.7M | $32.3M | $62.1M | $92.7M | $115.1M | $67.8M | $1.6M | $1.1M |
| Property, Plant & Equipment | $2.3M | $2.8M | $3.0M | $2.5M | $1.9M | $949.6K | $196.8K | $156.1K |
| Goodwill | — | — | — | — | $14.7M | — | — | — |
| Intangible Assets (Excl. Goodwill) | $7.2M | $26.1M | $26.4M | $26.8M | $27.2M | — | — | — |
| Total Assets | $24.7M | $63.6M | $95.3M | $123.1M | $160.0M | $71.2M | $2.2M | $1.6M |
| Liabilities | ||||||||
| Accounts Payable | $1.9M | $3.3M | $1.5M | $952.3K | $607.5K | $598.3K | $6.0K | $149.0K |
| Total Current Liabilities | $3.5M | $7.3M | $5.7M | $3.9M | $12.6M | $4.1M | $328.1K | $2.4M |
| Long-Term Debt | — | — | — | — | — | — | — | $1.9M |
| Total Liabilities | $4.1M | $9.7M | $9.3M | $8.6M | $25.6M | $4.5M | $478.1K | $2.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-80.4M | $-33.5M | $4.6M | $39.9M | $54.2M | $17.5M | $-25.0M | $-18.7M |
| Total Stockholders' Equity | $20.6M | $53.9M | $85.6M | $114.5M | $134.5M | $66.7M | $1.7M | $-1.1M |